$156.24 +0.46 (%) Salix Pharmaceuticals Ltd - NASDAQ

Sep. 30, 2014 | 04:00 PM

Partner Headlines

  1. Morning Market Losers

    Benzinga | Sep. 30, 2014 | 09:51AM EST
  2. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD | Sep. 29, 2014 | 18:32PM EST
  3. Stocks Fade More In Late Trade; GoPro Hangs Tough

    IBD | Sep. 29, 2014 | 15:14PM EST
  4. Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance

    IBD | Sep. 29, 2014 | 13:32PM EST
  5. Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix

    Benzinga | Sep. 28, 2014 | 11:05AM EST
  6. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD | Sep. 27, 2014 | 08:02AM EST
  7. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 26, 2014 | 08:02AM EST
  8. Valeant: Glaucoma Drug Is Potential Blockbuster

    IBD | Sep. 25, 2014 | 13:47PM EST
  9. Wave Of Selling Hits Stocks; IPO CyberArk Extends Gains

    IBD | Sep. 25, 2014 | 13:31PM EST
  10. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga | Sep. 24, 2014 | 21:09PM EST
  11. Pharma Buyout Bids Beat On

    IBD | Sep. 24, 2014 | 18:55PM EST
  12. Facebook, Three Other Leaders In Striking Distance

    IBD | Sep. 24, 2014 | 18:08PM EST
  13. Valeant Ends Prince Charming Act; Allergan Hopes Rise

    IBD | Sep. 24, 2014 | 15:55PM EST
  14. #PreMarket Primer: Wednesday, September 24: US Economy Looking Strong In The Third Quarter

    Benzinga | Sep. 24, 2014 | 07:13AM EST
  15. Ackman forewarns Allergan

    IBD | Sep. 23, 2014 | 18:45PM EST
  16. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  17. Stocks Finish Lower Among Takeover Rumors

    IBD | Sep. 23, 2014 | 18:06PM EST
  18. Dow Down 0.6%; CarMax Shares Fall After Q2 Results

    Benzinga | Sep. 23, 2014 | 15:13PM EST
  19. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  20. Ascena Retail Drops On Downbeat Earnings; CF Industries Shares Gain

    Benzinga | Sep. 23, 2014 | 12:43PM EST
  21. Stocks Fall Modestly; New Issue Alibaba Extends Losses

    IBD | Sep. 23, 2014 | 11:56AM EST
  22. Allergan-Ackman Flame War Reignites On Salix Rumors

    IBD | Sep. 23, 2014 | 11:47AM EST
  23. Markets Mixed; Carnival Profit Tops Street View

    Benzinga | Sep. 23, 2014 | 11:20AM EST
  24. Indexes Pare Losses As Salix Soars On Buyout Talk

    IBD | Sep. 23, 2014 | 10:56AM EST
  25. Benzinga's Volume Movers

    Benzinga | Sep. 23, 2014 | 10:25AM EST
  26. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 23, 2014 | 10:10AM EST
  27. Morning Market Movers

    Benzinga | Sep. 23, 2014 | 09:38AM EST
  28. Stock Futures Lower, But Salix Soars On Buyout Talk

    IBD | Sep. 23, 2014 | 08:55AM EST
  29. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 23, 2014 | 08:14AM EST
  30. #PreMarket Primer: Tuesday, September 23: First Airstrikes In Syria Begin

    Benzinga | Sep. 23, 2014 | 07:28AM EST
  31. US Stock Futures Fall Ahead Of Economic Data

    Benzinga | Sep. 23, 2014 | 07:16AM EST
  32. Stocks To Watch For September 23, 2014

    Benzinga | Sep. 23, 2014 | 05:24AM EST
  33. Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.

    Benzinga | Sep. 22, 2014 | 22:50PM EST
  34. Benzinga's M&A Chatter for Monday September 22, 2014

    Benzinga | Sep. 22, 2014 | 18:17PM EST
  35. IBD 50 Stocks Setting Up, Including These 5 Medicals

    IBD | Sep. 19, 2014 | 18:35PM EST
  36. Salix Secures Additional Intellectual Property Relating To Rifaximin

    Benzinga | Sep. 18, 2014 | 07:31AM EST
  37. Stocks Erase Modest Gains; Netflix Gaps Below 50-Day Line

    IBD | Sep. 16, 2014 | 12:12PM EST
  38. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD | Sep. 16, 2014 | 11:36AM EST
  39. UCERIS 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA

    Benzinga | Sep. 15, 2014 | 17:32PM EST
  40. Nasdaq Sinks As Tesla, Other Highfliers Get Hit

    IBD | Sep. 15, 2014 | 16:31PM EST
  41. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  42. Credit Suisse Sees Downside In Shares Of Salix Pharmaceuticals, Ltd.

    Benzinga | Sep. 12, 2014 | 11:28AM EST
  43. Stocks Drag Lower Despite Data; Conversant Soars On ADS Buyout

    IBD | Sep. 12, 2014 | 10:37AM EST
  44. Four Stock Spotlight Names Near Buy Points

    IBD | Sep. 5, 2014 | 18:45PM EST
  45. IBD 50 Showing Little Distress, But Few Big Winners

    IBD | Sep. 5, 2014 | 18:45PM EST
  46. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  47. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  48. After Big Run, Does Chip Designer NXP Have More Left?

    IBD | Aug. 26, 2014 | 17:27PM EST
  49. S&P 500 Marks New High As Indexes Hold Gains

    IBD | Aug. 21, 2014 | 16:30PM EST
  50. SALIX PHARMACEUTICALS

    IBD | Aug. 20, 2014 | 18:56PM EST
Trading Center